Artificial Disc Replacement Market Research Report with Outlook, Strategies, Challenges, Geography Trends

 

Global Artificial Disc Replacement Market is expected to grow at a CAGR of 15% during forecasted period.On regional basis, global artificial disc replacement market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America has a leading market for artificial disc replacement. Due to increasing aging population, increasing healthcare expenditure and higher success rate of artificial disc replacements has boosted the artificial disc replacements market in North America. Europe has the second largest market for artificial disc replacements. Germany, UK and franc are the major contributor of the market. Favorable reimbursement policy structure, well-developed healthcare infrastructure and increasing healthcare expenditure are the driving factor for the market growth. While Asia Pacific is the fastest growing region for the growth of the market. A huge population base and rapid development in Asia Pacific region has provided fuel for the growth of the market.

Artificial disc replacement is the method used to treat back pain. It is also known as total disc replacement in which there is a replacement of degenerated intervertebral disc in spine column. This treatment is used to treat chronic and severe back pain and cervical pain. The major driving factors for global artificial disc replacement market are growing prevalence of degenerative spine condition because of increasing aging population across the globe, preference for minimal surgical procedure and many advantages over traditional spine fusion procedure. High cost of devices and lack of uniform reimbursement are major restraining factors for the market growth.



Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1395

Competitive Analysis

Some of the major players in the global artificial disc replacement market are Alphatec Spine Inc. (US), Medtronic Inc. (UK), De Puy Spine (US), Stryker Corporation (US), Smith & Nephew Plc (UK), Orthovita Inc. (US), Globus Medical (US), Zimmer Spine Inc (US), Aesculap Implant Systems (US), NuVasive (US), Zimmer-Biomet (US) and many more

Due to increasing aging population across the globe many of the companies are in the race to introduce better option of artificial disc replacement for patient suffering from back pain. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Alphatec Spine, Inc., an US headquartered medical technology company which develop and launch promotes spinal fusion products. They has introduced DISCOCERV a cervical disc prosthesis to preserve the physiological mobility of the cervical spine.

Medtronic Inc. is a medical device company headquartered Ireland. They has introduced Prestige LP and Bryan cervical disc used to maintain the distance between two adjacent cervical vertebrae.

Globus Medical, a US headquartered medical device company focus on development and design of musculoskeletal implants that promote healing in patients with spine disorders. They has introduced SECURE-C for treatment of an anterior cervical discectomy.

Stryker Corporation is a Fortune 500 medical technologies based in US. They has introduced OASYS, Reflex, Escalate and Aviator for the treatment of spine damage.

Segmentation:

Global artificial disc replacement market is segmented on the basis of type into cervical disc replacement, lumber disc replacement and other. Lumber disc replacement the most popular treatment option among the people suffering from back pain. On the basis of material they are segmented as metal and biopolymer

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/artificial-disc-replacement-market-1395

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Comments

Post a Comment

Popular posts from this blog

Peripheral Nerve Stimulators Market in Global Industry: Demands, Insights, Research and Forecast 2020-2027

Image
  Global peripheral nerve stimulators market expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 750.36 million in 2018 and is projected to grow at a CAGR of 7.7% over the forecast period. Peripheral Nerve Stimulators is expected to grow at a significant growth rate. The major factors influencing the growth of the market include; rising economic growth, increasing geriatric devices, increasing growth in technological advancement in the field of medical devices, rising neurological disorders, rising incidence of chronic health problems, and others. Segmentation The global peripheral nerve stimulators market has been segmented into product, and end user. Based on product, the market is segmented into transcutaneous and implantable. Based on end user, the peripheral nerve stimulators market is segmented into hospitals & clinics, ambulatory centers, specialty center, and others. Request Free Sample Copy at...
Read more

Proteomics Market 2020: Global Industry Exhibits Huge Growth by Top Key Players

Image
  Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. The Global Proteomics Market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation proteomics workflows. ...
Read more